Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness

The reappraisal said a definite people of drugs had small objective benefit, but galore Alzheimer’s experts criticized the analysis, saying it unfairly lumped failed drugs with 2 precocious approved treatments.